Wang Ting, Zhang Huiyue, Feng Rui, Ren Jieru, Xu Xinping, Sun Shujuan
Shandong Second Provincial General Hospital, Jinan, China.
PeerJ. 2025 Feb 12;13:e18825. doi: 10.7717/peerj.18825. eCollection 2025.
Linezolid is an oxazolidinone antibiotic that is mainly permitted to treat Gram-positive bacterial infections. Recent studies have shown that linezolid also has antibacterial effects on several other bacteria outside the package insert, including , non-tuberculous mycobacteria (NTM), , , and anaerobes, . Interestingly, linezolid also has an inhibitory effect on fungi. This review focuses on the antibacterial activity of linezolid against microorganisms outside its antibacterial spectrum. We mainly listed the number of the tested strains, the minimum inhibitory concentration (MIC) range, MIC, and MIC of linezolid against those pathogens outside the package insert. The results showed that among these tested pathogens, linezolid displayed strong inhibitory effects against , , and , with an MIC range of ≤2 μg/mL. As for NTM, linezolid exhibited moderate to potent inhibitory effects against the strains of different species with an MIC range of 0.06-128 μg/mL. Moreover, linezolid was reported to have a species-dependent inhibitory effect on anaerobes at a concentration range of 0.003-16 μg/mL. Furthermore, linezolid could enhance azoles and amphotericin B's antifungal activity on synergistically. It is hoped that this analysis can provide data for expanding the application of linezolid, make the off-label drug use have more compelling evidence, and provide clues for the development of new drugs.
利奈唑胺是一种恶唑烷酮类抗生素,主要被批准用于治疗革兰氏阳性菌感染。最近的研究表明,利奈唑胺对药品说明书之外的其他几种细菌也有抗菌作用,包括非结核分枝杆菌(NTM)、、、和厌氧菌、。有趣的是,利奈唑胺对真菌也有抑制作用。本综述聚焦于利奈唑胺对其抗菌谱外微生物的抗菌活性。我们主要列出了受试菌株的数量、利奈唑胺对药品说明书之外那些病原体的最低抑菌浓度(MIC)范围、MIC以及MIC。结果显示,在这些受试病原体中,利奈唑胺对、和表现出强烈的抑制作用,MIC范围≤2μg/mL。至于NTM,利奈唑胺对不同菌种的菌株表现出中度至强效的抑制作用,MIC范围为0.06 - 128μg/mL。此外,据报道利奈唑胺在0.003 - 16μg/mL的浓度范围内对厌氧菌有菌种依赖性抑制作用。此外,利奈唑胺可协同增强唑类和两性霉素B对的抗真菌活性。希望该分析能为扩大利奈唑胺的应用提供数据,使超说明书用药有更令人信服的证据,并为新药研发提供线索。